Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2012
05/03/2012WO2012057220A1 Percutaneously absorbed preparation
05/03/2012WO2012057212A1 Percutaneous absorption type formulation
05/03/2012WO2012057103A1 Pharmaceutical composition
05/03/2012WO2012056956A1 Vesicle composition, and external skin preparation and cosmetic, each containing same
05/03/2012WO2012056509A1 Pharmaceutical composition
05/03/2012WO2012056471A2 Novel process for preparing dexibuprofen ready to compress granules
05/03/2012WO2012056465A1 A process for preparing curcumin encapsulated chitosan alginate sponge useful for wound healing
05/03/2012WO2012056452A2 Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
05/03/2012WO2012056402A2 Formulations and methods for attenuating respiratory depression induced by opioid overdose
05/03/2012WO2012056387A2 A dermaceutical gel made using sodium fusidate and a process to make it
05/03/2012WO2012056299A1 Nasal compositions of vitamin b12
05/03/2012WO2012056251A1 Inflammatory disease
05/03/2012WO2012056233A1 Coated beads
05/03/2012WO2012056229A1 Inflammatory disease
05/03/2012WO2012056031A1 Modified starch derivative-based matrix for colon targeting
05/03/2012WO2012055971A1 Microvesicles derived from atheroprotective endothelial cells for the treatment and prevention of atherosclerotic diseases
05/03/2012WO2012055947A2 Preparation of orodispersible films
05/03/2012WO2012055944A1 Oral pharmaceutical film formulation for bitter-tasting drugs
05/03/2012WO2012055941A1 Multilayer pharmaceutical composition comprising telmisartan and amlodipine
05/03/2012WO2012055933A1 Liposome-based construct comprising a peptide modified through hydrophobic moieties
05/03/2012WO2012055708A1 Medicinal product comprising hydromorphone, with improved shelf-life
05/03/2012WO2012055571A1 Ophthalmic composition
05/03/2012WO2012055568A1 Liposomal drug composition containing a polymeric guanidine derivative
05/03/2012WO2012055020A1 Thermosensitive liposomes
05/03/2012WO2012054999A1 Compositions based on propolis nanocapsules which can be used as carriers for substances of interest, methods for producing same and use thereof
05/03/2012WO2012033730A3 Punctal plug containing drug formulation
05/03/2012WO2012032417A3 Compositions comprising a fatty acid oil mixture, a free fatty acid, and a statin
05/03/2012WO2012032415A3 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form, a surfactant, and a statin
05/03/2012WO2012032414A3 Compositions comprising a fatty acid oil mixture, a surfactant, and a statin
05/03/2012WO2012031342A3 Polymer system and method for encapsulating human amylin and agonist analogues, and use thereof; released amylin functional evaluation method
05/03/2012WO2012024530A3 Therapeutic peptide-polymer conjugates, particles, compositions, and related methods
05/03/2012WO2012020097A3 Use of binders for manufacturing storage stable formulations
05/03/2012WO2012005500A3 Time-delayed sustained release pharmaceutical composition comprising dapoxetine for oral administration
05/03/2012WO2012002760A3 Method for treating and diagnosing cancer by using cell-derived microvesicles
05/03/2012WO2012002759A3 Microvesicles derived from cell protoplast, and use thereof
05/03/2012WO2011162560A3 Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved
05/03/2012WO2011151079A3 Preparation for use in ophthalmology and retinal surgery
05/03/2012WO2011144673A3 Long - acting formulations of insulins
05/03/2012WO2011139479A3 High shear application in drug delivery
05/03/2012WO2011139255A3 Pharmaceutical compositions comprising cefetamet
05/03/2012WO2011139254A3 Pharmaceutical formulations compising cefuroxime axetil
05/03/2012WO2011134962A3 Orally disintegrating tablet containing acarbose
05/03/2012WO2011133685A3 Nanoparticle targeting to ischemia for imaging and therapy
05/03/2012WO2011130753A3 Functionalized nano- and micro-materials for medical therapies
05/03/2012WO2011128634A3 Over the counter pharmaceutical compositions
05/03/2012WO2011128627A3 Oral veterinary pharmaceutical and nutraceutical compositions
05/03/2012WO2011128623A3 Improvements relating to antiviral compositions
05/03/2012WO2011126839A3 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
05/03/2012WO2011120903A3 A fast dissolving pharmaceutical composition
05/03/2012WO2011119995A3 Formulations and methods of use
05/03/2012WO2011119903A3 Emulsions for microencapsulation comprising biodegradable surface-active block copolymers as stabilizers
05/03/2012WO2011112922A3 Co-crystals and pharmaceutical formulations comprising the same
05/03/2012WO2011107755A3 Immediate/delayed drug delivery
05/03/2012WO2011107750A3 Delayed prolonged drug delivery
05/03/2012WO2011107749A3 Pulsatile drug release
05/03/2012WO2011085957A3 Process for the preparation of pharmaceutical compositions for the sustained release of somatostatin analogs
05/03/2012WO2011082796A3 Temperature-dependent activation of catalytic nucleic acids for controlled active substance release
05/03/2012WO2011060944A3 Active pharmaceutical ingredient capsules and polyunsaturated fatty acid esters
05/03/2012WO2011015308A3 Destructive disposal of medical active ingredients in transdermal therapeutic systems
05/03/2012US20120110683 Non-human animal model of myocardial infarction and method for creating the same
05/03/2012US20120109113 Safety limits for closed-loop infusion pump control
05/03/2012US20120109106 Drug delivery system for accelerated subcutaneous absorption
05/03/2012US20120109051 Devices, methods, and kits for taste modification and controlling food intake
05/03/2012US20120109045 Encapsulation of Microbubbles Within the Aqueous Core of Microcapsules
05/03/2012US20120109044 Prevention of myocardial infraction induced ventricular expansion and remodeling
05/03/2012US20120108880 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
05/03/2012US20120108664 Transdermal delivery of beneficial substances effected by a hostile biophysical environment
05/03/2012US20120108643 Method of increasing the extent of absorption of tizanidine
05/03/2012US20120108622 Pharmaceutical formulation containing gelling agent
05/03/2012US20120108621 Pharmaceutical preparation containing oxycodone and naloxone
05/03/2012US20120108555 Mixtures or Organic Compounds for the Treatment of Airway Diseases
05/03/2012US20120107408 Pharmaceutical microparticles
05/03/2012US20120107407 Bone graft and biocomposite for prosthetic dentistry
05/03/2012US20120107406 Dry Powder Formulations
05/03/2012US20120107405 Method for the dry dispersion of nanoparticles and the production of hierarchical structures and coatings
05/03/2012US20120107404 Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
05/03/2012US20120107403 Bladder reconstruction
05/03/2012US20120107402 Process for analyzing and establishing dosage size in an ingestible film
05/03/2012US20120107401 Osteoconductive matrices comprising statins and methods of using the same
05/03/2012US20120107400 Sustained release composition of theraputic agent
05/03/2012US20120107399 Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
05/03/2012US20120107398 Pharmaceutical compositions
05/03/2012US20120107397 Pharmaceutical compositions of valsartan
05/03/2012US20120107396 Compositions For The Treatment of Central Nervous System Disorders Including Depression Employing Novel Drug Combination Therapy To Reduce Suicidality In Patients
05/03/2012US20120107395 Probiotic Soft Gel Compositions
05/03/2012US20120107394 Immuno-compatible hydrogel system
05/03/2012US20120107393 Pellets for Delivery of Biologically Active Substances
05/03/2012US20120107392 Use of huperzine for disorders
05/03/2012US20120107391 Therapy of platinum-resistant cancer
05/03/2012US20120107390 Feline infectious peritonitis vaccine
05/03/2012US20120107389 Amphoteric liposomal compositions for cellular delivery of small rna molecules for use in rna interference
05/03/2012US20120107388 Hemostatic composition, apparatus, and methods
05/03/2012US20120107387 Laminated sheet and process for producing the same
05/03/2012US20120107386 Composition and method for incorporating nutrients into condiments and use thereof in cooked foods
05/03/2012US20120107385 Method of treating conditions associated with overactive bladder
05/03/2012US20120107383 Osteoconductive matrices comprising calcium phosphate particles and statins and methods of using the same
05/03/2012US20120107382 Articles incorporating absorbent polymer and ceragenin compound
05/03/2012US20120107381 Powder formulations of potassium-binding active agents
05/03/2012US20120107380 Methods of saponifying xanthophyll esters and isolating xanthophylls
05/03/2012US20120107378 High strength carbo substances
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 2991